Sagefield Capital’s STAAR Surgical STAA Stock Holding History

Sagefield Capital’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,970	Closed	-$295K	–	132
2025 Q3	$295K	Buy	+10,970	New	+$262K	0.03%	101

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sagefield Capital's STAA Position: Q4 2025 in Review

Sagefield Capital sold out of STAAR Surgical (STAA) in Q4 2025, closing a stake of 10,970 shares — an estimated $295K sold.

Sagefield Capital first reported a position in STAA in Q3 2025 and held it in 1 quarter. The position peaked at $295K in Q3 2025. 201 funds tracked by Wall St. Rank hold STAA as of Q4 2025.

Sagefield Capital reported no remaining STAAR Surgical position as of Q4 2025 after selling out during the quarter.
Sagefield Capital sold 10,970 STAAR Surgical shares in Q4 2025, an estimated $295K.
Sagefield Capital first reported a position in STAAR Surgical in Q3 2025 and held it in 1 quarter.
Sagefield Capital's STAAR Surgical position peaked at $295K in Q3 2025.
201 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2025.

Based on Sagefield Capital's 13F filing for Q4 2025, filed 17 Feb 2026.